Zobrazeno 1 - 10
of 72
pro vyhledávání: '"AKTAŞ, Habibullah"'
Autor:
Uzun, Soner, Durdu, Murat, Yürekli, Aslan, Mülayim, Mehmet K., Akyol, Melih, Velipaşaoğlu, Sevtap, Harman, Mehmet, Taylan‐Özkan, Ayşegül, Şavk, Ekin, Demir‐Dora, Devrim, Dönmez, Levent, Gazi, Umut, Aktaş, Habibullah, Aktürk, Aysun Ş., Demir, Gülay, Göktay, Fatih, Gürel, Mehmet S., Gürok, Neşe G., Karadağ, Ayşe S., Küçük, Özlem S.
Publikováno v:
International Journal of Dermatology; Dec2024, Vol. 63 Issue 12, p1642-1656, 15p
Autor:
ERTUĞRUL, Gökşen1 goksenycl@hotmail.com, AKTAŞ, Habibullah1
Publikováno v:
Duzce Medical Journal. 2022, Vol. 24 Issue 1, p74-77. 4p.
Publikováno v:
Volume: 13, Issue: 2 61-63
Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi
Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi
Dear Editor, The COVID-19 pandemic has been such a nightmare for about a year. The COVID-19 is a disease that mainly concerns the specialties of infectious and chest diseases. However, there was such a global pandemic that the experts of these specia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::f3d83e5e5df8e3f843ed6b52f61cc5a2
https://dergipark.org.tr/tr/pub/gutfd/issue/65466/1011833
https://dergipark.org.tr/tr/pub/gutfd/issue/65466/1011833
Autor:
TÜRSEN, Belma, AKTAŞ, Habibullah
Publikováno v:
Volume: 14, Issue: 3 504-508
Mersin Üniversitesi Sağlık Bilimleri Dergisi
Mersin Üniversitesi Sağlık Bilimleri Dergisi
Amaç: Omalizumab, antihistaminlere dirençli kronik ürtiker tedavisinde kullanılan monoklonal anti IgE antikorudur. Her dört haftada bir uygulama önerilmektedir.Yöntem: Kronik ürtiker tanısıyla izlenen 15 hastanın subkutan omalizumab tedavi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::428ab201cff4ff1b313ff525c2c7102f
https://dergipark.org.tr/tr/pub/mersinsbd/issue/64896/1007723
https://dergipark.org.tr/tr/pub/mersinsbd/issue/64896/1007723
Autor:
ERTUĞRUL, Gökşen, AKTAŞ, Habibullah
Publikováno v:
Volume: 17, Issue: 2 15-19
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Amaç: Verruka vulgaris, human papilloma virüslerinin neden olduğu benign epiteliyal proliferatif bir hastalıktır. Siğil tedavisinde topikal ve intralezyonel Dvitamini uygulamaları etkili yöntemlerdir. Bununla birlikte, hastalık ile serum D v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::43d361faf88092744a2f7e89422c25ac
https://dergipark.org.tr/tr/pub/ksutfd/issue/71235/987056
https://dergipark.org.tr/tr/pub/ksutfd/issue/71235/987056
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
AKTAŞ, Habibullah1 aktashabib@hotmail.com, ERTUĞRUL, Gökşen2
Publikováno v:
Firat Tip Dergisi. 2018, Vol. 23 Issue 4, p164-167. 4p.
Publikováno v:
International Journal of Clinical Practice
Hydroxychloroquine (HCQ) is a drug that is used for both chemoprophylaxis and treatment of COVID‐19. At the moment, HCQ maintain its popularity and tens of thousands of people across the world are still receiving the current drug.1After the COVID
Publikováno v:
Archives of Clinical and Experimental Medicine, Vol 3, Iss 3, Pp 198-200 (2018)
Archives of Clinical and Experimental Medicine
Archives of Clinical and Experimental Medicine
Medicinalleech application is a common traditional therapy used for various disorders inmany cultures for thousands of years. Although it is usually a safe method,serious side effects can also be seen. As a rare side effect of this method, cutaneousp
Publikováno v:
Volume: 36, Issue: 3 91-93
Journal of Experimental and Clinical Medicine
Journal of Experimental and Clinical Medicine
Captopril inhibits angiotensin-converting enzyme and it is the most used sub-lingual drug in emergency departments to decrease blood pressure. Sublingual captopril is safe, effective and useful in treating hypertensive urgency. However, it is known t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::50a30761ca5efb4b72f26928eb70bd6b
https://dergipark.org.tr/tr/pub/omujecm/issue/52307/638851
https://dergipark.org.tr/tr/pub/omujecm/issue/52307/638851